Journal of Lung Cancer Epidemiology

Aims and Scope

Journal of Lung Cancer Epidemiology (JLCE) is a premier, open-access, peer-reviewed international journal dedicated to advancing the scientific understanding of lung cancer epidemiology. JLCE serves as a platform for cutting-edge research that explores the etiology, prevention strategies, and clinical implications of lung cancer, with a strong emphasis on public health impact and evidence-based medicine.  
 

JLCE covers all aspects of lung cancer epidemiology, including but not limited to:  

• Molecular & Genetic Epidemiology: Investigating genetic susceptibility, biomarkers, and personalized risk assessments.  
• Risk Factor Analysis: Examining the role of smoking, air pollution, occupational exposure, and other environmental carcinogens.  
• Cancer Prevention & Public Health Strategies: Evaluating tobacco control policies, early detection programs, and global prevention initiatives.  
• Epidemiologic Trends & Surveillance: Tracking incidence, prevalence, and survival trends across different populations.  
• Clinical Implications of Epidemiology: Exploring how epidemiologic data informs early diagnosis, treatment decisions, and patient outcomes.  
• Biomarker Research & Genetic Testing: Investigating novel diagnostic and prognostic markers for lung cancer.  
• Health Disparities & Global Perspectives: Addressing socioeconomic and geographic disparities in lung cancer burden and access to care.  
• Occupational & Environmental Carcinogens: Studying exposure-related lung cancer risks in industrial and environmental settings.  
• Artificial Intelligence & Big Data in Epidemiology: Leveraging machine learning and computational approaches for lung cancer risk prediction and analysis.  

The editorial team encourages manuscripts from all relevant disciplines, including but not limited to 

• Public health
• Symptoms of Lung Cancer
• Oxidative phosphorylation
• Small cell lung cancer
• Molecular biology
• Biostatistics
• Non-Small Cell Lung Cancer
• Lung Cancer Staging
• Squamous cell cancer
• e-cigarettes
• lung health
• Allied medical sciences
• Incidence and mortality
• Squamous cell carcinoma
• Oncology
• Lung cancer
• Radiotherapy and Chemotherapy
• Lung cancer incidence
• Lung cancer mortality
• Lung cancer survival
• Lung cancer screening
• Lymphocytes
• Lung cancer risk factors
• Smoking and lung cancer
• Secondhand smoke and lung cancer
• Occupational exposure and lung cancer
• Environmental exposure and lung cancer
• Genetics and lung cancer
• Biomarkers for lung cancer
• Early detection of lung cancer
• Lung cancer staging
• Lung cancer treatment
• Surgery for lung cancer
• Adenocarcinoma
• Radiation therapy for lung cancer
• Chemotherapy for lung cancer
• Immunotherapy for lung cancer
• Targeted therapy for lung cancer
• Mesothelioma
• Palliative care for lung cancer
• Lung cancer clinical trials
• Lung cancer prevention
• Lung cancer awareness
• Lung cancer education
• Lung cancer disparities
• Lung cancer epidemiology
• Lung cancer incidence trends
• Lung cancer mortality trends
• Lung cancer survival rates
• Lung cancer screening guidelines
• Lung cancer screening eligibility
• Lung cancer screening adherence
• Lung cancer screening controversies
• Lung cancer risk assessment
• Lung cancer risk reduction
• Lung cancer risk communication
• Lung cancer risk perception
• Lung cancer prevention policies
• Lung cancer treatment decision-making
• Lung cancer treatment outcomes
• Lung cancer treatment complications
• Lung cancer survivorship